Similarly, the receptors VEGFR2 (KDR) and NRP1 were decreased or relatively unchanged in prostate primary tumors while they were up-regulated in renal cell carcinoma (Fig. 1c, d for prostate, Fig. 1g, h for kidney). The gene discussed is KDR; the disease is hereditary clear cell renal cell carcinoma.